lhf-535
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 31, 2019 (NCT03993704)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Lassa virusINHIBITOR
Lassa virus inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
CC(C)Oc1ccc(-n2cnc3cc(/C=C\c4ccc(C(C)(C)O)cc4)ccc32)cc1- Mol. weight
- 412.53 g/mol
- Lipinski Ro5
- 1 violation(s)
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4537239 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03993704 | Phase 1 | Jul 31, 2019 | Kineta Inc., Wellcome Trust |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Kineta Inc. | For profit | 1 | 1 | 1 | 2019 |
| Wellcome Trust | Academic/Hospital | 1 | 0 | 1 | 2019 |
2 organizations
Page 1 / 1